Search research articles
Contact Us
Filters
Showing results (121-130 of 183) with videos related to
Page
of 19
Sort By:
Blood Advances
|
January 16, 2026
Improved survival and healthcare utilization with CAR-T vs historical care in relapsed-refractory large B-cell lymphoma
Tiana Kordbacheh, Kelvin Kw Chan, Michael Crump, et al.
Human Genetics
|
December 7, 2010
Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease
Olivia Belbin, Minerva M Carrasquillo, Michael Crump, et al.
Blood Neoplasia
|
October 28, 2025
Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy
Chathuri Abeyakoon, Sita Bhella, Katrina Hueniken, et al.
British Journal of Haematology
|
February 19, 2020
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder
Michael D Jain, Ryan Lam, Zhihui Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13
William P Peters, Gary L Rosner, James J Vredenburgh, et al.
Seminars in Oncology
|
February 1, 2017
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
Joy Mangel, Rena Buckstein, Kevin Imrie, et al.
Seminars in Oncology
|
February 14, 2002
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
Joy Mangel, Rena Buckstein, Kevin Imrie, et al.
Blood Neoplasia
|
June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)
Sarit Assouline, Anca Prica, Diego Villa, et al.
Molecular Informatics
|
August 3, 2016
The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing
Pekka Kohonen, Emilio Benfenati, David Bower, et al.
Journal of the National Cancer Institute
|
December 18, 2016
General Biomarker Recommendations for Lymphoma
Lisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 183) with videos related to
Sort By:
Page
of 19
Blood Advances
|
January 16, 2026
Improved survival and healthcare utilization with CAR-T vs historical care in relapsed-refractory large B-cell lymphoma
Tiana Kordbacheh, Kelvin Kw Chan, Michael Crump, et al.
Human Genetics
|
December 7, 2010
Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease
Olivia Belbin, Minerva M Carrasquillo, Michael Crump, et al.
Blood Neoplasia
|
October 28, 2025
Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy
Chathuri Abeyakoon, Sita Bhella, Katrina Hueniken, et al.
British Journal of Haematology
|
February 19, 2020
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder
Michael D Jain, Ryan Lam, Zhihui Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13
William P Peters, Gary L Rosner, James J Vredenburgh, et al.
Seminars in Oncology
|
February 1, 2017
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
Joy Mangel, Rena Buckstein, Kevin Imrie, et al.
Seminars in Oncology
|
February 14, 2002
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma
Joy Mangel, Rena Buckstein, Kevin Imrie, et al.
Blood Neoplasia
|
June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)
Sarit Assouline, Anca Prica, Diego Villa, et al.
Molecular Informatics
|
August 3, 2016
The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing
Pekka Kohonen, Emilio Benfenati, David Bower, et al.
Journal of the National Cancer Institute
|
December 18, 2016
General Biomarker Recommendations for Lymphoma
Lisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Page
of 19